<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="Publishing Group UKLondon pmcid: 7384729387 doi: 10.1038/s41371-020-0387-4 : Review Article" exact="Covid-19" post="and the cardiovascular system: a comprehensive review http://orcid.org/0000-0001-6864-8805AzevedoRafael Bellottihttp://orcid.org/0000-0002-4130-5148BotelhoBruna"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in 2012 [1]. SARS-CoV-2 presents a transmissibility"/>
 <result pre="respiratory or intestinal infections in humans and animals [2]. The" exact="SARS-CoV-2 infection" post="occurs through the coupling of S-protein located on the"/>
 <result pre="diverging or not related to the cardiovascular complications associated with" exact="SARS-CoV-2 infection" post="were excluded from the revision. Articles that were not"/>
 <result pre="to a higher risk of developing severe disease due to" exact="SARS-CoV-2 infection" post="[7]. A retrospective cohort study included 126 patients with"/>
 <result pre="with COVID-19 without hypertension. Among hypertensives, 21.3% had more severe" exact="SARS-CoV-2 infection" post="and higher death rate, 10.3% vs. 6.4%, when compared"/>
 <result pre="when compared to controls, indicating that hypertension enhances inflammation in" exact="SARS-CoV-2 infection." post="Interestingly, hypertensive patients undergoing anti-hypertensive therapy with RAAS blockers"/>
 <result pre="Hypertension seems to enhance the inflammatory profile in patients with" exact="SARS-CoV-2 infection," post="inferring that resistant hypertension possiblyÃ‚ increases even more the"/>
 <result pre="of patients with resistant hypertension and COVID-19 [9]. Myocarditis The" exact="SARS-CoV-2 infection," post="mainly in its severe forms, apparently induce an aggression"/>
 <result pre="controlled, open-label trial with 199 patients, investigating lopinavir/ritonavir efficacy for" exact="SARS-CoV-2 infection," post="only 1.1% of the patients in the lopinavir/ritonavir group"/>
 <result pre="severity was assessed in 6,272 patients who tested positive for" exact="SARS-CoV-2 infection;" post="the use of ACEi/ARBs was not associated with an"/>
 <result pre="association between the use of these drugs and more severe" exact="SARS-CoV-2 infection" post="was demonstrated [33]. Therefore, ACEi/ARBs are possibly potential drugs"/>
 <result pre="with more favorable outcomes. Conclusion Hypertension is strongly associated with" exact="SARS-CoV-2 infection" post="possibly due to the proinflammatory state of this chronic"/>
 <result pre="proven protease inhibitorCell20201812718010.1016/j.cell.2020.02.05232142651 3.WuZMcGooganJMCharacteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in ChinaJAMA202032312394210.1001/jama.2020.2648 4.YeQWangBMaoJThe pathogenesis and treatment of"/>
 <result pre="Cardiol20207529507310.1016/j.jacc.2020.04.03132311448 21.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ Thromb Haemost2020181094910.1111/jth.1481732220112 22.Lakkireddy DR, Chung MK,"/>
 <result pre="or without concomitant azithromycin among hospitalized patients testing positive for" exact="coronavirus disease 2019" post="(COVID-19). JAMA Cardiol. 2020;e201834. 10.1001/jamacardio.2020.1834 26.HancoxJCHasnainMViewegWVCrouseELBaranchukAAzithromycin, cardiovascular risks, QTc"/>
</results>
